WallStSmart

Boston Scientific Corp (BSX)vsGeneral Dynamics Corporation (GD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

General Dynamics Corporation generates 162% more annual revenue ($52.55B vs $20.07B). BSX leads profitability with a 14.4% profit margin vs 8.0%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).

BSX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 8.7Quality: 5.5
Piotroski: 4/9

GD

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 4.7Quality: 7.5
Piotroski: 6/9Altman Z: 2.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXUndervalued (+1.2%)

Margin of Safety

+1.2%

Fair Value

$70.62

Current Price

$69.78

$0.84 discount

UndervaluedFair: $70.62Overvalued
GDSignificantly Overvalued (-212.4%)

Margin of Safety

-212.4%

Fair Value

$114.87

Current Price

$352.50

$237.63 premium

UndervaluedFair: $114.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX4 strengths · Avg: 8.3/10
Market CapQuality
$101.28B9/10

Large-cap with strong market position

PEG RatioValuation
0.758/10

Growing faster than its price suggests

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

GD1 strengths · Avg: 9.0/10
Market CapQuality
$95.31B9/10

Large-cap with strong market position

Areas to Watch

BSX1 concerns · Avg: 4.0/10
P/E RatioValuation
35.1x4/10

Premium valuation, high expectations priced in

GD2 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.4%4/10

0.4% earnings growth

PEG RatioValuation
2.512/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.

Bull Case : GD

The strongest argument for GD centers on Market Cap.

Bear Case : BSX

The primary concerns for BSX are P/E Ratio.

Bear Case : GD

The primary concerns for GD are EPS Growth, PEG Ratio.

Key Dynamics to Monitor

BSX profiles as a growth stock while GD is a value play — different risk/reward profiles.

BSX carries more volatility with a beta of 0.70 — expect wider price swings.

BSX is growing revenue faster at 15.9% — sustainability is the question.

BSX generates stronger free cash flow (1.0B), providing more financial flexibility.

Bottom Line

BSX scores higher overall (63/100 vs 54/100) and 15.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

General Dynamics Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

General Dynamics Corporation (GD) is an American aerospace and defense corporation. It is headquartered in Reston, Fairfax County, Virginia.

Visit Website →

Want to dig deeper into these stocks?